All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Factors Associated with Tuberclosis-HIV Co-Infection in Diagnosis in the Nzanza Health Zone

DOI: 10.4236/oalib.1107105, PP. 1-14

Subject Areas: Infectious Diseases

Keywords: HIV infection, Factors Associated, Tuberclosis, Nzanza Health Zone

Full-Text   Cite this paper   Add to My Lib

Abstract

Aim: To determine the factors associated with the increase in the proportion of HIV-infected TB patients of Kiamvu and Baobab Tuberculosis Screening and Treatment Health Center (TSTHC) in the Nzanza HZ, Matadi, between January 2012 and December 2017. Methods: This was a control case study of 187 HIV-positive TB patients and 187 HIV-negative TB patients followed at the Nzanza HZ Tuberculosis Screening and Treatment Health Center (TSTHC) from January 1, 2012 to December 31, 2017. We used Pearson’s Khi square test and homogeneity as well as logistic regression. This identified the factors associated with TB/HIV co-infection. Results: HIV-positive TB patients had a high daily household income [OR: 2.90; p: 0.000]) than HIV-negative people. The majority of HIV-positive TB patients had unprotected sex with a casual partner prior to diagnosis [OR: 1.82; p: 0.000]) than HIV-negative. After adjustment, alcohol intake [OR: 12.2; p: 0.004]) and extra pulmonary forms of tuberculosis [OR: 31.5; 0.002] were associated with increased TB/HIV co-infection. Conclusion: Alcohol intake and extra-pulmonary forms of tuberculosis were factors associated with increased TB/HIV co-infection. Awareness of TB patients may help reduce the risk of HIV infection.

Cite this paper

Nzuzi, C. N. , Onyamboko, M. , Kokolomami, J. , Tukadila, H. A. , Natuhoyila, A. N. and Longo-Mbenza, B. (2021). Factors Associated with Tuberclosis-HIV Co-Infection in Diagnosis in the Nzanza Health Zone. Open Access Library Journal, 8, e7105. doi: http://dx.doi.org/10.4236/oalib.1107105.

References

[1]  Joint United Nations Programme on HIV/AIDS (2014) Un rapport de la situation mondial sur le VIH’, Communique de Presse. Joint United Nations Programme on HIV/AIDS, Geneve, 1
[2]  Desenclos, J.-C., Dabis, F. and Semaille, C. (2013) épidémiologie du VIH dans le monde: Particularités de l’épidémie au Nord et au Sud. Virologie, 17, 132-144.
[3]  Organisation Mondiale de la Santé (2017) Le VIH/Sida. Aide-mémoire Actualisé. http://www.who.int/mediacentre/factsheets/fs360/fr/
[4]  Organisation Mondiale de la Santé (2016) Mettre fin au VIH/Sida d’ici 2030: Cadre d’action dans la région africaine de l’OMS 2016-2020. Bureau régional de L’AFR/ RC66/11, Organisation Mondiale de la Santé, Geneve, 1.
[5]  Ministère de la santé publique (2014) Deuxième enquête démographique et de santé (EDS-RDC II 2013-2014), Rapport Final, Democratic Republic of Congo, Kinshasa, 27.
[6]  PNLS RDC (2015) Cap vers l’objectif 90-90-90. Rapport Annuel, 15.
[7]  Chelli, J., Bellazreg, F., Aouem, A., Hattab, Z., Mesmia, H. and Ben Lasfar, N. (2016) Causes de décès des patients infectés par le VIH dans le centre de Tunisie. The Pan African Médial Journal, 25, Article No. 105. https://doi.org/10.11604/pamj.2016.25.105.9748
[8]  Raizada, N., Chauhan, L.S., Khera, A., Sokhey, J., Wares, D.F., Sahu, S., et al. (2008) HIV Seroprevalence among Tuberculosis Patients in India. PLoS ONE, 3, e2970. https://doi.org/10.1371/journal.pone.0002970
[9]  Organisation Mondiale de la Santé (2016) Rapport sur la lutte contre la tuberculose dans le monde. Organisation Mondiale de la Santé, Geneve, 1
[10]  Organisation Mondiale de la Santé (2014) Stratégie pour mettre fin à la tuberculose d’ici 2035. Rapport de lutte contre la tuberculose, Organisation Mondiale de la Santé, Geneve.
[11]  Organisation Mondiale de la Santé (2009) Focus sur la coïnfection VIH/Tubercu- lose. Rapport de la journée mondiale de la tuberculose 24 mars. Organisation Mondiale de la Santé, Geneve.
[12]  Organisation Mondiale de la Santé and Stop TB Partnership (2010) Questions prioritaires de recherche sur la coïnfection tuberculose/VIH dans les pays prévalents pour le VIH et disposant de ressources limitées. Organisation Mondiale de la Santé, Geneva, 3
[13]  Joint United Nations Programme on HIV/AIDS and Organisation Mondiale de la Santé (2009) Point sur l’epidemie mondial du sida.
[14]  Cain, K.P., Anekthananon, T., Burapat, C., Akksilp, S., Mankhatitham, W., Srinak, C., et al. (2009) Les causes de décès chez les personnes infectées par le VIH qui ont tuberculosis, Thailand. Emerging Infectious Diseases, 15, 258-164. https://doi.org/10.3201/eid1502.080942
[15]  Organisation Mondial de la Santé (2010) Global Tuberculosis Control’ Rapport. Organisation Mondial de la Santé, Geneve.
[16]  World Health Organization (2016) Global Report Tuberculosis. World Health Organization, Geneve, 1.
[17]  World Health Organization (2017) Global Report Tuberculosis. World Health Organization, Geneve, 17, 29.
[18]  World Health Organization (2015) Global Report Tuberculosis. World Health Organization, Geneve, 27, 96.
[19]  Joint United Nations Programme on HIV and AIDS (2017) Estimation ONUSIDA.
[20]  PNLT Kongo Central (2016) Rapport Annuel 2011-2016.
[21]  World Health Organization (2014) Global Report Tuberculosis. World Health Organization, Geneva, 4.
[22]  Fujiwara et Coll (2012) Mise en œuvre d’activités conjointes de lutte contre la tuberculose et le VIH: Un guide programmatique. Union Internationale Contre la Tuberculose et les Maladies Respiratoires, Paris, 5.
[23]  Fiogbe, A., Adjoh, K.S., Ouedraogo, A.R., Maiga, A.I., Wateba, M.I., Okemba-Okombi, F.H., et al. (2015) Co-Infection VIH/Tuberculose en milieu rural au Benin: Cas De La Zone Sanitaire Djougou-Ouake-Copargo (Nord-Ouest Benin). Mali Medical, Tome XXX, 33.
[24]  Organisation Mondiale de la Santé(2016) Rapport sur la lutte contre la tuberculose dans le monde. Organisation Mondiale de la Santé, Geneva, 3.
[25]  Soyam, V.C, Das, J., Rajeeva, T.C., Boro, P. and Kohli, C. (2016) Prevalence and Socio-Demographic Correlates of VIH among Tuberculosis Patients of DOTS Centre in Delhi. Asian Journal of Medical Sciences, 7, 53-58. https://doi.org/10.3126/ajms.v7i1.12744
[26]  Arun Mohan, M.V., Tejaswi, H.J. and Ranganath, T.S. (2016) Socio-Demographic Profile of TB-HIV Co-Infected Adults and It’s Association with Tuberculosis Treatment Outcome, in a South Indian City. International Journal of Community Medicine and Public Health, 3, 2-4.
[27]  Nascimento do Prado, T., Miranda, A.E., de Souza, F.M., dos Santos Dias, E., Sousa, L.K.F., Arakaki-Sanchez, D., et al. (2014) Factors Associated with Tuberculosis by HIV Status in the Brazilian National Surveillance System: A Cross Sectional Study. BMC Infectious Diseases, 14, Article No. 415. https://doi.org/10.1186/1471-2334-14-415
[28]  Musafiri, J., Mbayo, P.M., Bakaswa, G., Kaswa, M. and Likwela, J.L. (2013) HIV Seroprevalence among Tuberculosis Patients in Kisangani in the Democratic Republic of Congo. Santé Publique, 25, 483-490. https://doi.org/10.3917/spub.134.0483
[29]  Akilimali, P.Z., Tshilumbu, J.M.K., Mavila, A.K. and Kaba, D.K. (2013) Issues thérapeutiques du traitement antituberculeux dans le contexte de la co-infection VIH-tuberculose: Cohorte du centre de Kabinda à Kinshasa, République démocratique du Congo. Revue d’épidémiologie et de Santé Publique, 63, 387-393. https://doi.org/10.1016/j.respe.2015.09.007
[30]  Alemu, Y.M., Awoke, W. and Wilder-Smith, A. (2016) Determinants for Tuberculoses in HIV-Infected Adults in Northwest Ethiopia. BMJ Open, 6, Article ID: e009058. https://doi.org/10.1136/bmjopen-2015-009058
[31]  Akilimali, P.Z., Mafuta, E.M., Kaba, D.N., Kimpanga, P., Kayembe, N.J.M., Hernandez, J., et al. (2009) Issue thérapeutique des patients tuberculeux suivis dans les centres de santé de diagnostic et de traitement de la Ville de Matadi, dans le contexte du VIH. Annals of African Medicine, 5, 920-925.
[32]  Batista, J., de Albuquerque, M., Maruza, M., Ximenes, R., Santos, M., Montarroyos, U.R., et al. (2013) Incidence and Risk Factors for Tuberculosis in People Living with HIV: Cohort from HIV Referral Health Centers in Recife, Brazil. PLoS ONE, 8, e63916.
[33]  Yone, é.W.P., Kuaban, C. and Kengne, A.P. (2009) Impact de l’infection à VIH sur l’évolution de la tuberculose chez l’adulte à Yaoundé. Cameroun. Revue de Pneumologie Clinique, 68, 338-344. https://doi.org/10.1016/j.pneumo.2012.10.001
[34]  Goluba, J.E., Pronyk, P., Mohapi, L., Thsabangu, N., Moshabela, M., Struthers, H., et al. (2009) Isoniazid Preventive Therapy, HAART and Tuberculosis Risk in HIV-Infected Adults in South Africa: A Prospective Cohort. AIDS, 23, 631-636. https://doi.org/10.1097/QAD.0b013e328327964f
[35]  Kibret, K.T., Yalew, A.W., Belaineh, B.G. and Asres, M.M. (2013) Determinants Factors Associated with Occurrence of Tuberculosis among Adult People Living with HIV after Antiretroviral Treatment Initiation in Addis Ababa, Ethiopia: A Case Control Study. PLoS ONE, 8, e64488. https://doi.org/10.1371/journal.pone.0064488
[36]  Baromètre Santé (2013) Usages de tabac, d’alcool et de drogues illicites et pratiques de jeu en région Paca. ORS Paca—SESSTIM (UMR 912 Inserm-IRD-Université Aix-Marseille, Marseille
[37]  Mbopi-Kéou, F.X., Dempouo Djomassi, L. and Monebenimp, F. (2012) étude des facteurs liés à l’observance au traitement antiretroviral chez les patients suivis à l’unité de prise en charge du VIH/SIDA de l’hôpital de district de Dschang. Cameroun. The Pan African Medical Journal, 12, Article No. 55. https://doi.org/10.11604/pamj.2012.12.55.1521
[38]  PNLT (2014) Guide PATI 5. PNLT, 19-21.
[39]  Magadi, M. and Desta, M. (2011) Multilevel Analysis of Determinants and Cross-National Variations of HIV Seropositivity in Sub-Saharan Africa: Evidence from the DHS. Health & Place, 17, 1067-1083. https://doi.org/10.1016/j.healthplace.2011.06.004
[40]  Shuper, P.A., Neuman, M., Kanteres, F., Baliunas, D., Joharchi, N. and Rehm, J. (2010) Causal Considerations on Alcohol and HIV/AIDS—A Systematic Review. Alcohol and Alcoholism, 45, 159-166. https://doi.org/10.1093/alcalc/agp091

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

微信:OALib Journal